Frontiers in Pharmacology | Neuropharmacology

Original Research

Published on 14 Oct 2024

Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress

in Neuropharmacology

Yexiang Chen
Yunhao Jiang
Xingcong Jiang
Caiyu Zhai
Yifei Wang
Chi Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472468

916 views

Brief Research Report

Published on 10 Oct 2024

Chronic exposure to inhaled vaporized cannabis high in Δ9-THC suppresses Adderall-induced brain activity

in Neuropharmacology

Jack M. Ognibene
Rajeev I. Desai
Praveen P. Kulkarni
Craig F. Ferris

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413812

2,593 views

Original Research

Published on 09 Oct 2024

Fentanyl enhances immune cell response through TLR4/MD-2 complex

in Neuropharmacology

Chiara Chemello
Laura Facci
Emma Marcolin
Giovanni Eugenio Ramaschi
Massimo Barbierato
Pietro Giusti
Chiara Bolego
Morena Zusso

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468644

1,159 views

Original Research

Published on 07 Oct 2024

Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine

in Neuropharmacology

Amélie Jean Jacques
Nazzareno D’Avanzo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445509

1,019 views

Editorial

Published on 03 Oct 2024

Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases

in Neuropharmacology

Bhagavathi Sundaram Sivamaruthi
Natarajan Suganthy
Carolina Pellegrini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499072

684 views

Mini Review

Published on 02 Oct 2024

Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome

in Neuropharmacology

Xuehai Ma
Weimin Li
Jun Ma
Zhongcheng Han
Shoulong Deng
Sutian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491563

804 views

Brief Research Report

Published on 02 Oct 2024

Isoflurane-lipid emulsion injection as an anticonvulsant and neuroprotectant treatment for nerve agent exposure

in Neuropharmacology

Jishnu K. S. Krishnan
John R. Moffett
Narayanan Puthillathu
Erik A. Johnson
Aryan M. Namboodiri

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466351

694 views

Original Research

Published on 02 Oct 2024

Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations

in Neuropharmacology

Mohd Saeed
Ashanul Haque
Ambreen Shoaib
Syed Mohd Danish Rizvi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395014

1,413 views

Review

Published on 02 Oct 2024

Single-cell profiling of cellular changes in the somatic peripheral nerves following nerve injury

in Neuropharmacology

Li Zhao
Chunyi Jiang
Bin Yu
Jianwei Zhu
Yuyu Sun
Sheng Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448253

1,186 views
1 citation

Brief Research Report

Published on 02 Oct 2024

Synergistic effects of peripheral GABA and GABA-transaminase inhibitory drugs on food intake control and weight loss in high-fat diet-induced obese mice

in Neuropharmacology

Tomoka Nagao
Jason D. Braga
Siyi Chen
Masubon Thongngam
Maesaya Chartkul
Noriyuki Yanaka
Thanutchaporn Kumrungsee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1487585

3,025 views
1 citation

Original Research

Published on 01 Oct 2024

Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain

in Neuropharmacology

Xiaocui Yuan
Yixiao Guo
Huiyuan Yi
Xuemei Hou
Yulong Zhao
Yuying Wang
Hong Jia
Sani Sa’idu Baba
Man Li
Fuquan Huo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439448

1,048 views

Correction

Published on 30 Sep 2024

Corrigendum: Long-term efficacy and reduced side-effects of buprenorphine in patients with moderate and severe chronic pain

in Neuropharmacology

Alfonso Papa
Anna Maria Salzano
Maria Teresa Di Dato
Vincenzo Desiderio
Pietro Buonavolontà
Pietro Mango
Elisabetta Saracco
Dario Tammaro
Livio Luongo
Sabatino Maione

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491886

552 views

Correction

Published on 27 Sep 2024

Corrigendum: Activation of EphrinB2/EphB2 signaling in the spine cord alters glia-neuron interactions in mice with visceral hyperalgesia following maternal separation

in Neuropharmacology

Shufen Guo
Yu Wang
Qingling Duan
Wei Gu
Qun Fu
Zhengliang Ma
Jiaping Ruan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491784

516 views

Original Research

Published on 27 Sep 2024

Unraveling the pathogenic mechanism of a novel filamin a frameshift variant in periventricular nodular heterotopia

in Neuropharmacology

Chunran Xue
Yishu Wang
Jing Peng
Sisi Feng
Yangtai Guan
Yong Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1429177

718 views
1 citation

Original Research

Published on 26 Sep 2024

Sex differences in nicotine intake and relapse behavior in nicotine-dependent adult wistar rats

in Neuropharmacology

Ranjithkumar Chellian
Azin Behnood-Rod
Adriaan W. Bruijnzeel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415219

956 views
2 citations

Original Research

Published on 26 Sep 2024

Deletion of arrestin-3 does not reduce drug-seeking behavior in a longitudinal paradigm of oral morphine self-administration

in Neuropharmacology

Sarah Warren Gooding
Lindsey Felth
Randi Foxall
Zachary Rosa
Kyle Ireton
Izabella Sall
Joshua Gipoor
Anirudh Gaur
Madeline King
Noah Dirks

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438037

677 views
2 citations

Navigation group

Articles

Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress

Chronic exposure to inhaled vaporized cannabis high in Δ9-THC suppresses Adderall-induced brain activity

Fentanyl enhances immune cell response through TLR4/MD-2 complex

Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine

Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases

Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome

Isoflurane-lipid emulsion injection as an anticonvulsant and neuroprotectant treatment for nerve agent exposure

Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations

Single-cell profiling of cellular changes in the somatic peripheral nerves following nerve injury

Synergistic effects of peripheral GABA and GABA-transaminase inhibitory drugs on food intake control and weight loss in high-fat diet-induced obese mice

Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain

Corrigendum: Long-term efficacy and reduced side-effects of buprenorphine in patients with moderate and severe chronic pain

Corrigendum: Activation of EphrinB2/EphB2 signaling in the spine cord alters glia-neuron interactions in mice with visceral hyperalgesia following maternal separation

Unraveling the pathogenic mechanism of a novel filamin a frameshift variant in periventricular nodular heterotopia

Sex differences in nicotine intake and relapse behavior in nicotine-dependent adult wistar rats

Deletion of arrestin-3 does not reduce drug-seeking behavior in a longitudinal paradigm of oral morphine self-administration